🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the effectiveness of niraparib in ...
Status
Active Not Recruiting
Location
Urology Centers Of Alabama
Start Date
2019-01-25
Trial ID
NCT03748641
The goal of this clinical research study is to find out how treatment with ...
Status
Completed
Location
Multiple Locations
Start Date
2009-12
Trial ID
NCT01088529
Treatments Being Tested
The purpose of this study is to: a) establish the recommended phase 2 dose ...
Status
Active Not Recruiting
Location
Urological Associates of Southern Arizona, P.C.
Start Date
2018-03-02
Trial ID
NCT03431350
Treatments Being Tested
The purpose of this study is to investigate potential drug-drug interaction...
Status
Active Not Recruiting
Location
Multiple Locations
Start Date
2014-07-09
Trial ID
NCT02123758
Treatments Being Tested
To evaluate whether Fuzuloparib plus AA-P is superior to placebo plus AA-P ...
Status
Active Not Recruiting
Location
Alaska Oncology and Hematology LLC
Start Date
2021-03-18
Trial ID
NCT04691804
The purpose of the study is to determine if the combination of niraparib wi...
Status
Active Not Recruiting
Location
Urology Centers Of Alabama
Start Date
2020-09-23
Trial ID
NCT04497844
The purpose of this study is to compare the radiographic progression-free s...
Status
Active Not Recruiting
Location
Multiple Locations
Start Date
2014-11-26
Trial ID
NCT02257736
Treatments Being Tested
To assess activity of abiraterone-re-challenge in patients with advanced pr...
Status
Terminated
Location
Cantonal Hospital Chur
Start Date
2016-01
Trial ID
NCT02656615
Treatments Being Tested
ABIFOOD study is a randomized open-labelled, phase I study to evaluate food...
Status
Completed
Location
Hospital Universitario Virgen del Rocío
Start Date
2014-05-12
Trial ID
NCT02730975
Metastatic castration resistant prostate cancer causes approximately 258400...
Status
Unknown
Location
Multiple Locations
Start Date
2018-05-01
Trial ID
NCT03449719
Treatments Being Tested